Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507598 · ClinicalTrials.gov registry record
Metabolomics-Based Detection of Colorectal Cancer
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 69
- Enrollment target
NCT00507598: Completed study, sponsored by Indiana University.
NCT00507598 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00507598 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to collect specimens to perform metabolic profiling of serum and urine from patients with colorectal cancer, colon polyps and healthy patients.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2007-07 |
| Est. Completion | 2012-11 |
What the finished NCT00507598 record still lists
NCT00507598 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT00507598 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00507598 about?
NCT00507598 is a clinical study titled "Metabolomics-Based Detection of Colorectal Cancer". The purpose of this study is to collect specimens to perform metabolic profiling of serum and urine from patients with colorectal cancer, colon polyps and healthy patients.
What is the current status of trial NCT00507598?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2007-07. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00507598?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT00507598?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia